FDA Calendar: 2H09 Binary Event Trades [View article]
BIEL stated in 6/19/09 PR they have about 720 million shares of stock outstanding, but stock price has still increased by over 700% in past month: www.google.com/finance...
Stock Valuation -- There are currently approximately 720 million outstanding shares, which represent a total market capitalization of approximately $7.2 million.
> I would advise extreme caution on BIEL. In the first quarter of 2009 > alone (January-March) the company nearly doubled its shares outstanding > from 266.9 million to 492.2 million with sales at 0.005 per share > and I would not be shocked if significant additional shares were > issued since then.
FDA Calendar Updates: King Pharma, Pain Therapeutics [View article]
No position in HEB. I typically do not hold small/micro-cap biomed stocks thru binary decisions as part of the extreme trading strategy that I write about (see below for a summary). I am long BDSI because chance of approval appears near certain based on the Company's statements and conference call on June 15.
A high risk/reward trading approach to consider for speculative traders is investing a small amount of money that you can afford to lose in a basket of stocks included in Extreme FDA and Clinical Trial Calendar Trades, which are highlighted in periodic articles at BioMedReports. Another approach is to buy a basket of stocks well ahead of their expected binary events before the trading crowd arrives and causes an increase in the share price and trading volume.
FDA Calendar: 2H09 Binary Event Trades [View article]
www.google.com/finance...
Stock Valuation -- There are currently approximately 720 million outstanding shares, which represent a total market capitalization of approximately $7.2 million.
finance.yahoo.com/news...
On Jul 27 10:30 PM Dan Weiss wrote:
> I would advise extreme caution on BIEL. In the first quarter of 2009
> alone (January-March) the company nearly doubled its shares outstanding
> from 266.9 million to 492.2 million with sales at 0.005 per share
> and I would not be shocked if significant additional shares were
> issued since then.
FDA Calendar Updates: King Pharma, Pain Therapeutics [View article]
A high risk/reward trading approach to consider for speculative traders is investing a small amount of money that you can afford to lose in a basket of stocks included in Extreme FDA and Clinical Trial Calendar Trades, which are highlighted in periodic articles at BioMedReports. Another approach is to buy a basket of stocks well ahead of their expected binary events before the trading crowd arrives and causes an increase in the share price and trading volume.
On Jul 08 09:00 PM ArunNewaskar wrote:
> Mike what is your current position on HEB ?
FDA Calendar Updates: King Pharma, Pain Therapeutics [View article]
On Jul 08 10:42 AM wary wrote:
> Mike whats your current position on BDSI ?